|
Parameter (Units)
|
Placebo (n = 20)
|
LI10903F (n = 20)
|
P value
|
|---|
|
Liver Function
|
|
SGOT (U/L)
|
−1.50 ± 3.63
|
−2.55 ± 6.36
|
0.397
|
|
SGPT (U/L)
|
−7.65 ± 2.65
|
−11.70 ± 4.65
|
0.839
|
|
Cardiac Function
|
|
Systolic BP (mm Hg)
|
−2.40 ± 3.00
|
−12.53 ± 3.92
|
0.105
|
|
Diastolic BP (mm Hg)
|
−0.70 ± 2.07
|
−5.05 ± 2.89
|
0.975
|
|
Pulse rate (beats/min)
|
0.80 ± 1.48
|
−0.11 ± 1.06
|
0.786
|
|
Metabolic panel
|
|
Cholesterol (mg/dL)
|
12.20 ± 7.47
|
−1.2 ± 6.83
|
0.119
|
|
Triglycerides (mg/dL)
|
−8.76 ± 17.32
|
−26.50 ± 30.27
|
0.041*
|
|
LDL (mg/dL)
|
−23.43 ± 7.08
|
−11.64 ± 13.37
|
0.155
|
|
HDL (mg/dL)
|
−3.04 ± 1.23
|
1.33 ± 4.44
|
0.873
|
|
Fasting Glucose (mg/dL)
|
−6.20 ± 10.68
|
−16.15 ± 7.35
|
0.445
|
- Results are presented as Mean ± SEM. *Statistical significant difference is between the placebo and the herbal groups.
- Abbreviations: SGOT=Serum glutamic oxaloacetic transaminase; SGPT=Serum glutamic pyruvic transaminase; LDL=Low density lipoproteins; HDL=High density lipoproteins.
